About: MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Sector: Healthcare
Industry: Medical Devices
Latest price: $1.73 (+1.17%)
MXCT NASDAQ MaxCyte Inc
MaxCyte Inc share price
Atividade de preço de MXCT
Último preço
$ 1,730
Variação (24h)
0,02 USD (1,17%)
Volume
1.14M
Volume (média 4 sem.)
-
Abertura
$ 1,73
Variação do dia
$ 1,62 - $ 1,76
Fechamento anterior
$ 1,71
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
MXCT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals